Blog
Archive February 2024
All of the articles archived for the month that you have specified are displayed below.
Drug Supply Chain Security Act: Join APhA's letter to the FDA
- By: admin
- On: 02/13/2024 14:41:50
- In: Coronavirus
APhA’s Government Affairs team needs your feedback on their survey about the Drug Supply Chain Security Act (DSCSA) implementation at your pharmacy. FDA is interested in better understanding the status of the supply chain’s progress in implementing the DSCSA requirements that went into effect on November 27, 2023.
FDA Revises Letter of Authorization for Paxlovid EUA
- By: admin
- On: 02/13/2024 13:18:01
- In: KPhA Updates
On January 29, 2024, the FDA revised the Paxlovid EUA, stating that the EUA-labeled Paxlovid distributed by the US government will only remain authorized through March 8, 2024. On January 31, 2024, HHS-ASPR issued a COVID-19 Therapeutics Stakeholder letter via email to all Paxlovid providers with instructions for return of product. Highlights of both letters can be found below.
Updates to the Board-Authorized Protocols
- By: admin
- On: 02/13/2024 13:16:28
- In: Board Authorized Protocols
Updates to the Board-Authorized Protocols
On January 24, 2024, the Board of Pharmacy approved revisions for the following board-authorized protocols:
Acute Group A Streptococcal Pharyngitis
Acute Influenza Infection Antiviral Therapy Protocol
For the past several months, the Protocol Review Committee has been working diligently to review and update these protocols to ensure they are aligned with 201 KAR 2:380 and with current clinical guidelines. Any pharmacy that has been utilizing a previously approved version is expected to use the latest version of a board-authorized protocol to ensure compliance with 201 KAR 2:380(2)(1)(b).
As a reminder, you must submit any fully executed protocol to the Board’s registry at pharmacy.board@ky.gov.
Join Us for Our First Monthly Medical Billing Workshop
- By: admin
- On: 02/13/2024 13:14:27
- In: KPhA Updates
PBM Reform Legislation Filed in the State Senate
- By: admin
- On: 02/08/2024 14:47:56
- In: Legislative Update
Board of Pharmacy Requests KPhA Member Feedback
- By: admin
- On: 02/05/2024 14:34:18
- In: KPhA Updates
The Winter Journal has Arrived: Your Voice is Vital
- By: admin
- On: 02/05/2024 14:29:04
- In: KPhA Updates
Instead, let's move intentionally through the warmer-than-normal February forecast with the WINTER issue of The Kentucky Pharmacist close to our chest and heed the call to advocate for our profession at Pharmacy Day at the Capitol.
Law Enforcement Access to Protected Health Information – What’s Your Policy?
- By: admin
- On: 02/04/2024 14:44:26
- In: KPhA Updates
Understanding and adhering to the HIPAA Privacy Rule is required for covered entities who handle protected health information (PHI), but because the Privacy Rule was designed to be flexible, implementation of policies and procedures to meet the Privacy Rules can vary from covered entity to covered entity. Look no further than the December 12, 2023 letter from the United States Senate Committee on Finance (herein, “The Committee”) for evidence of this variation and how it can seriously impact the privacy of sensitive patient data.
Dose of Democracy: Weekly Legislative Update
- By: admin
- On: 02/02/2024 10:03:05
- In: Legislative Update
The Committee voted unanimously in support of the bill to, after being amended in the Committee meeting, allow pharmacists to immunize patients ages 5 and older under protocol. The bill proceeded to the House floor for its first reading yesterday afternoon and will receive a vote upon its third reading in the Chamber.
Click here to read HB 274 and its Committee Substitute language
Click here to ask your Representative to vote in support of HB 274
Click here to watch Representative Bentley and President Hudspeth’s testimony in the KET Archives
KPhA President Dr. Brooke Hudspeth to Testify in Support of HB 274
- By: admin
- On: 02/01/2024 09:55:56
- In: Legislative Update
KPhA President Dr. Brooke Hudspeth will testify today, February 1, at noon during the Health Services Committee, chaired by Representative Kimberly Moser (R-Kenton), in favor of HB 274: legislation that would allow pharmacists to vaccinate individuals down to age 3 under a prescriber-approved protocol.
Representative Danny Bentley (R-Russell) filed HB 274, which would amend KRS 315 to grant pharmacists immunization authority for patients ages 3. The KPhA Government Affairs Team's hard work at the Capitol and effective coalition building resulted in a swath of bi-partisan support as HB 274 now has 19 co-sponsors. The bill is expected to be amended in committee today to reflect a compromise with other stakeholders and healthcare providers. The committee substitute will bring the immunization age in the bill from age 3 up to 5 years old.